08/04/2026
Training specialists and using the diagnostic tools offered by frontier science to tackle Parkinson’s and other neurodegenerative diseases that affect movement is the purpose that brought together the efforts of the Center for Nanoscience and Nanotechnology (CEDENNA) and the Movement Disorders Center (CETRAM).
Both institutions signed a framework collaboration agreement for the joint development of research, innovation and training activities, as part of the ANID Project that promotes the creation of strategic collaboration networks and the training of advanced human capital.
The Movement Disorders Center, CETRAM, is a Chilean institution dedicated to the study, diagnosis, treatment and clinical research of various neurodegenerative disorders and diseases, but also to training specialists, as its members place special emphasis on training and scientific output.
Directed by Dr. Pedro Chana, it recently received international financial support from the Michael J. Fox Foundation to strengthen its clinical, scientific and training capabilities, an international recognition that will allow the training of physicians who will both provide clinical support to current patients and serve as researchers to strengthen CETRAM’s educational programs.
As highlighted by Dr. Dora Altbir, director of the Center for Nanoscience and Nanotechnology, CEDENNA, this task is “fully complementary to our efforts, as we can contribute advanced technical equipment and our researchers’ findings in nanobiomedicine to fulfill the common purpose of both institutions, committed to advancing frontier science in the service of patients”.
“Through the signed agreement, both institutions will boost their training, education, academic support and professional development efforts with academic, clinical and scientific activities, benefiting mutually from the results of these efforts, both in generating advanced human capital and in cutting-edge research on this type of disorder and the most advanced diagnostic and treatment tools,” stressed CETRAM director Dr. Pedro Chaná.
